Search

everythinglearnresearchcommunity

for

Search:↓

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

DPCP is effective for treating severe alopecia areata, but relapse is common.

Thrombospondin-1 is crucial for hair follicle regression and reduced blood vessel growth during the catagen phase.

Two patients had a unique form of trichothiodystrophy with reduced high-sulfur proteins in their hair.

ODC expression in mouse skin and tumors is varied and can be inhibited by retinoic acid or cycloheximide.

TA-Ado effectively promotes hair growth and reduces hair loss.

HGF combined with ADA is highly accurate for diagnosing tuberculous pleural effusion, especially in younger females.

An intact skin barrier is crucial to prevent infection in cases of tether-induced tenosynovitis.

A man developed severe skin reactions after using a treatment for hair loss.

A TP63 gene mutation causes significant hair loss and mild skin, nail, and tooth abnormalities.

Recombinant thymosin β4 promotes blood vessel growth and reduces muscle damage.

Dracorhodin perchlorate helps heal wounds in diabetic rats by reducing inflammation.

The FDA approved the first gene therapy for a blood disorder after overcoming early challenges and demonstrating patient benefits.

Direct-to-consumer teledermatology effectively treats male hair loss but may increase drug costs and requires monitoring for side effects.

Testosterone therapy improves physical function, strength, and body composition in older men with low testosterone levels.

The method accurately measures testosterone metabolites with high sensitivity and low environmental impact.

The TT/DHT ratio may help identify PCOS patients with severe metabolic issues.

A deep learning model was developed to help diagnose trichothiodystrophy by analyzing hair patterns.

DTDG in hair treatments reduces damage and preserves hair structure.

Combining PRP with Tressfix Serum is more effective for hair regrowth in telogen effluvium than using either alone.

Prostaglandin D2 increases testosterone production in skin cells through a process involving reactive oxygen species, which could be a new target for treating hair loss and other skin conditions driven by testosterone.

Temporal triangular alopecia is a lifelong condition with hairless patches on the side of the head that may be present from birth.

Blocking Wnt signaling in young mice causes thymus shrinkage and cell loss, but recovery is possible when the block is removed.

Topical immunotherapy with DPCP led to some hair regrowth in most pediatric alopecia areata patients, especially those with milder cases and longer treatment.

TRIV-509 quickly improves skin barrier and cell health in atopic dermatitis.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

Newly designed proteins can effectively degrade specific proteins in cells, offering a promising alternative for targeted protein degradation.

Truncated LTBP-1 disrupts TGF-beta signaling, affecting hair growth.

A new TP63 mutation was found in a baby with EEC syndrome, showing the need for TREC testing to check for immune issues.